How to Fight Antimicrobial Resistance
Drug-resistant microbes kill 700,000 people every year – more than three times the annual death toll from armed conflicts. A global challenge of this scale demands public-private collaboration, in which governments make up for market failures, and companies bring to bear their knowledge and experience.
ZURICH – Two weeks ago, G20 leaders committed to working together to address one of the world’s most pressing and perplexing security threats: antimicrobial resistance (AMR) – a fierce and evolving adversary against which conventional therapeutic weapons are of no use.